ENDPQ
ENDO HEALTH SOLUTIONS INC COM
ENDO HEALTH SOLUTIONS INC COM historical holders
total: 5
Miller Value Partners ENDO HEALTH SOLUTIONS INC COM transactions over time
- Total transactions:
- 26
- New positions:
- 1
- Sold out:
- 1
- Added:
- 15
- Reduced:
- 9
- Held since:
- 2016 Q2
- Held for:
- 25 quarters
- Latest activity:
- 2022 Q3
Bill Miller has been an institutional investor in ENDO HEALTH SOLUTIONS INC COM (ENDPQ) since 2016 Q2. According to 2026 Q1 report, Bill Miller doesn't hold any shares. The fund/company first acquired ENDPQ in 2016 Q2, initially purchasing about 1.75M shares. Since the initial investment, Miller Value Partners has made 25 more transactions in this position.
When did Bill Miller exit their ENDPQ position?
Bill Miller no longer holds ENDO HEALTH SOLUTIONS INC COM (ENDPQ). They sold off their entire position in 2022 Q3, closing out an investment that began in 2016 Q2.
When did Bill Miller first invest in ENDPQ?
Bill Miller first invested in ENDO HEALTH SOLUTIONS INC COM (ENDPQ) in 2016 Q2 at the reported quarter-end price of $15.59 per share, acquiring 1,745,475 shares in their initial purchase.
What is Bill Miller's average cost basis for ENDPQ?
Based on historical transaction data, Bill Miller's estimated cost basis for ENDO HEALTH SOLUTIONS INC COM (ENDPQ) is approximately $7.83 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $7.83
- Weighted AVG sell price:
- $3.77
ENDPQ transactions history by Miller Value Partners
26 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q3
|
0.00%
|
0
|
$0.47
|
|
-100% (-1,045,525)
|
-0.03%
|
|
2022 Q2
|
0.03%
|
1,045,525
|
$0.47
|
$487,000
|
-7.55% (-85,425)
|
-0%
|
|
2022 Q1
|
0.10%
|
1,130,950
|
$2.31
|
$2,612,000
|
+137.49% (+654,750)
|
+0.06%
|
|
2021 Q4
|
0.06%
|
476,200
|
$3.76
|
$1,791,000
|
-48.46% (-447,800)
|
-0.06%
|
|
2021 Q3
|
0.10%
|
924,000
|
$3.24
|
$2,994,000
|
+44.36% (+283,925)
|
+0.03%
|
|
2021 Q2
|
0.08%
|
640,075
|
$4.68
|
$2,996,000
|
+102.92% (+324,650)
|
+0.04%
|
|
2021 Q1
|
0.07%
|
315,425
|
$7.41
|
$2,337,000
|
+7.23% (+21,275)
|
+0%
|
|
2020 Q4
|
0.07%
|
$7.18
|
-3.39% (-10,325)
|
|||
|
2020 Q3
|
0.04%
|
$3.30
|
-96.53% (-8,465,935)
|
|||
|
2020 Q2
|
1.34%
|
$3.43
|
-32.97% (-4,313,985)
|
|||
|
2020 Q1
|
3.11%
|
$3.70
|
-15.97% (-2,487,100)
|
|||
|
2019 Q4
|
2.61%
|
$4.69
|
+4.74% (+704,405)
|
|||
|
2019 Q3
|
1.93%
|
$3.21
|
+51.75% (+5,069,790)
|
|||
|
2019 Q2
|
1.61%
|
$4.12
|
+8.22% (+744,240)
|
|||
|
2019 Q1
|
2.89%
|
$8.03
|
+1.13% (+101,575)
|
|||
|
2018 Q4
|
2.98%
|
$7.30
|
-0.81% (-72,670)
|
|||
|
2018 Q3
|
4.95%
|
$16.83
|
-6.92% (-670,585)
|
|||
|
2018 Q2
|
3.44%
|
$9.43
|
-0.53% (-51,590)
|
|||
|
2018 Q1
|
2.48%
|
$5.94
|
+23.12% (+1,830,305)
|
|||
|
2017 Q4
|
2.66%
|
$7.75
|
+5.88% (+439,565)
|
|||
|
2017 Q3
|
2.95%
|
$8.57
|
+22.36% (+1,366,050)
|
|||
|
2017 Q2
|
3.10%
|
$11.17
|
+29.97% (+1,409,010)
|
|||
|
2017 Q1
|
2.72%
|
$11.16
|
+39.22% (+1,324,475)
|
|||
|
2016 Q4
|
2.96%
|
$16.47
|
+92.59% (+1,623,500)
|
|||
|
2016 Q3
|
2.01%
|
$20.15
|
+0.46% (+7,950)
|
|||
|
2016 Q2
|
1.76%
|
$15.59
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.